兒童血友病65例臨床資料分析
[Abstract]:Objective: to study the clinical onset, diagnostic age, clinical manifestation and treatment of hemophilia in children. Methods: the clinical data of 65 children hemophilia patients admitted to the first affiliated Hospital of Guangxi Medical University from January 2005 to November 2011 were retrospectively analyzed. Results: of the 65 cases of hemophilia, 54 cases (83.08%) were hemophilia A, 13 cases (24.07%) were severe, 22 cases (40.74%) were medium, 17 cases (31.48%) were mild, and 2 cases (3.70%) were subclinical type. There were 11 cases (16.92%) of hemophilia B, 3 cases of severe type (27.27%), 4 cases of medium type (36.36%), 3 cases of mild type (27.27%) and 1 case of subclinical type (9.09%). Hemophilia A: hemophilia B / 4. 9 / 1. The median age of the first hemorrhage was 1 year old and the median age of the first diagnosis was 2 years and 2 months. Of the 65 children, 33 (50.77%) had symptoms of joint hemorrhage, 13 (81.25%) had severe hemophilia, 15 (57.69%) had moderate hemophilia. Among 65 cases, 17 cases (26.15%) developed joint malformations, including 7 cases (53.85%) of hemophilia A and 6 cases (27.27%) of medium-sized hemophilia. Hemophilia B was severe in 2 cases (66.67%) and medium in 2 cases (50.00%). There were 10 cases of severe hemorrhage, all of them were severe and medium-sized children. There were 27 cases of bleeding in more than two sites, of which 24 cases were severe and medium-sized. 18 cases (27.69%) had a clear family history of hemophilia, 62 cases had received replacement therapy 73 times, 29 cases (39.73%) were treated with coagulation factor infusion alone during acute hemorrhage, and 18 cases (27.69%) had a clear family history of hemophilia, 62 cases had received replacement therapy for 73 times, and 29 cases (39.73%) had only used coagulation factor infusion during acute hemorrhage. Coagulation factors were used in 35 cases (47.95%) with cold precipitation and / or fresh frozen plasma, and 9 cases (12.33%) with only cryoprecipitation or fresh frozen plasma. None of them were treated with prophylactic replacement therapy. 65 children were not systematically monitored for infectious diseases associated with blood products. One 14-year-old child was positive for anti-HCV antibody. Conclusion: (1) there is a difference between the age of first diagnosis and the age of first hemorrhage in hemophilia children, and there is delay in diagnosis, (2) the location of hemorrhage and the severity of hemorrhage are closely related to the clinical classification of hemophilia. (3) the incidence of joint hemorrhage and joint deformity was high; (4) there was a situation that replacement therapy was not timely and the rate of replacement therapy with factor preparation was low; (5) there was no systematic monitoring of infectious diseases associated with blood products in this group.
【學(xué)位授予單位】:廣西醫(yī)科大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2012
【分類號】:R725.5
【參考文獻】
相關(guān)期刊論文 前10條
1 丁培芳,張志傳,張心聲,顏新,申法奎;血友病甲患者抗-HCV和抗-HIV陽性率調(diào)查分析[J];中國輸血雜志;2002年03期
2 陸曄玲;丁秋蘭;戴菁;王鴻利;奚曉東;王學(xué)鋒;;血友病攜帶者與產(chǎn)前基因診斷[J];中國輸血雜志;2008年04期
3 白松婷;盧潔;盛光耀;許松濤;謝壘;彭韶;;彌凝治療兒童輕型血友病A的臨床觀察[J];中國當(dāng)代兒科雜志;2011年09期
4 劉敬忠,劉強,梁燕,王立榮,GuityNozary,肖白,朱章菱,周艷,劉亮,張晶,SteveS.Sommer;重型血友病甲基因診斷新技術(shù)的研究及其應(yīng)用[J];高技術(shù)通訊;1998年09期
5 曹江北;止血藥Desmopressin的藥理及應(yīng)用[J];國外醫(yī)學(xué).麻醉學(xué)與復(fù)蘇分冊;2000年01期
6 楊為群;蔣慧;;兒童血友病A36例臨床分析[J];臨床血液學(xué)雜志;2011年04期
7 王鴻利;;血友病的基因治療[J];內(nèi)科理論與實踐;2008年02期
8 王鴻利;王學(xué)鋒;;血友病診斷和治療的專家共識[J];內(nèi)科理論與實踐;2009年03期
9 李欽偉;李信業(yè);張心聲;喬文本;張雪芹;滕彬;申法奎;;224例血友病A患者輸血感染病毒狀況研究[J];山東醫(yī)藥;2007年16期
10 鐘小紅;李亞潔;趙潔;周春蘭;;血友病兒童家庭治療現(xiàn)狀調(diào)查[J];護理研究;2007年29期
,本文編號:2440245
本文鏈接:http://sikaile.net/yixuelunwen/eklw/2440245.html